{"data":{"billId":"115-hres-787","congress":115,"type":"HRES","number":"787","title":"Providing for consideration of the bill (H.R. 4566) to amend the Dodd-Frank Wall Street Reform and Consumer Protection Act to provide relief to nonbanks from certain stress test requirements under such Act; providing for consideration of the bill (H.R. 5247) to authorize the use of eligible investigational drugs by eligible patients who have been diagnosed with a stage of a disease or condition in which there is reasonable likelihood that death will occur within a matter of months, or with another eligible illness, and for other purposes; and for other purposes.","shortTitle":null,"originChamber":"House","introducedDate":"2018-03-19","updateDate":"2025-04-07T15:21:59Z","latestAction":{"actionDate":"2018-03-20","actionTime":"14:19:17","text":"Motion to reconsider laid on the table Agreed to without objection."},"policyArea":"Congress","sponsors":[{"bioguideId":"B001248","district":26,"firstName":"Michael","fullName":"Rep. Burgess, Michael C. [R-TX-26]","isByRequest":"N","lastName":"Burgess","middleName":"C.","party":"R","state":"TX","url":"https://api.congress.gov/v3/member/B001248?format=json"}],"cosponsorsCount":0,"committeesCount":1,"actionsCount":13,"textVersionsCount":2,"url":"https://civdotiq.org/bill/115-hres-787"},"meta":{"apiVersion":"v1","timestamp":"2026-10-03T14:16:55.378Z","source":"congress.gov","license":"MIT","documentation":"https://civdotiq.org/docs/api"}}